Stavanger UncomPlicatEd Elective PCI Same DaY Discharge Study (SPEEDY Study)
NCT ID: NCT02513108
Last Updated: 2019-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2015-12-31
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects on Health Status in Patients Early Discharged After Primary Percutaneous Coronary Intervention (PCI)
NCT01244841
Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)
NCT01068119
Percutaneous Coronary Intervention Versus Medical Treatment for Stable Angina Pectoris
NCT04496648
Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) Patients
NCT00474214
Reperfusion Time in ST Segment Elevation Myocardial Infarction (STEMI)
NCT00497419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Only patients with stable angina pectoris will be included in the study. After informed consent and successful procedure, the patients will be randomised to same day discharge or standard care. Same day discharge patients will be contacted by telephone the day after the procedure for follow-up conversation with particular emphasis on access site complications.
Both groups will receive quality of life questionnaire within a month for assessment of difference between the two strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
same day discharge
patients discharged same day after uncomplicated PCI
same day discharge
same day discharge after PCI for stable CAD
standard care
standard care where patients are discharged the day after procedure after adequate observation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
same day discharge
same day discharge after PCI for stable CAD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consenting for same day discharge
* Operator has assessed the patient and is in agreement
* Adequate observational facility
* Uncomplicated procedure
* Acceptable social network at home
* Uneventful post PCI ECG
* Adequate hemostasis of puncture site
Exclusion Criteria
* No-reflow/slow flow post PCI
* Sub-optimal PCI result
* Dissection type C-E
* Rest dissection after stent deployment
* Angiographic thrombus
* Guidewire perforation
* Clinical
* Advanced age
* Severe renal failure (GFR \< 30ml/min)
* Excessive bleeding risk
* Symptomatic heart failure
* Severe visual or hearing impairment
* Multi-vessel PCI (2 main vessels or left main)
* Use of GP IIb/IIIa inhibitors
* Social
* Living alone or has no telephone
* Long driving distance (\> 30-45 min)
* Patient/next to keen can“t communicate with health personnel without a translator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helse Stavanger HF
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nigussie Bogale, M.D, PhD
Role: PRINCIPAL_INVESTIGATOR
Helse Stavanger HF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stavanger University Hospital
Stavanger, Rogaland, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUS2015NIBO01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.